Scored 1630 on moca test3/29/2024 Dementia affects more than 50 million people worldwide and according to the most recent estimates, as the population ages, this number is predicted to quadruple ( GBD 2016 Dementia Collaborators, 2019). Therefore, further research is needed to determine how neuropsychological test scales and PET/CT measurements of disease progression interact.ĭiagnosis and treatment of dementia is challenging and has an impact on both social care and global health. However, there are few reports of large-scale 11C-PIB-PET/CT investigations that focus on the pathology of AD and MCI. Positron emission tomography (PET)/computed tomography (CT) and neuropsychological scales can be used to identify AD and mild cognitive impairment (MCI) early, provide a differential diagnosis, and offer early therapies to impede the course of the illness. 4Rehabilitation Therapeutics, School of Nursing of Jilin University, Changchun, Jilin, ChinaĪlzheimer’s disease (AD) is a critical health issue worldwide that has a negative impact on patients’ quality of life, as well as on caregivers, society, and the environment.3Department of Rehabilitation, China-Japan Union Hospital of Jilin University, Changchun, Jilin, China.2Department of Sleep Medicine, Guangxi Zhuang Autonomous Region People's Hospital, Nanning, Guangxi, China.1Department of Neurology, China-Japan Union Hospital of Jilin University, Changchun, Jilin, China.Qing Zhao 1 Xinxin Du 1 † Wenhong Chen 2 Ting Zhang 3,4 Zhuo Xu 3 *
0 Comments
Leave a Reply.AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |